R&D From promise to reality: Unlocking the true business potenti... The genomic medicine space has seen incredible success, but investors are overlooking it.
Digital Adopting AI platforms: A structured framework for thoughtful... The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.
R&D Proving ROI for digital endpoints The costs associated with clinical trials are a major bottleneck to drug development and affordability.
News Neumora laid low by depression trial failure The first of three phase 3 trials of Neumora's novel antidepressant navacaprant has ended in failure, wreaking havoc with its share price.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
